Literature DB >> 4906449

L-asparaginase.

J P Whitecar, G P Bodey, J E Harris, E J Freireich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4906449     DOI： 10.1056/NEJM197003262821307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

1.  Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro.

Authors:  L Bartalena; E Martino; A Pacchiarotti; S Balzano; M Falcone; V Sica; P Biddau; A Pinchera
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

Review 2.  Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors:  Wan Zhang; Peng Huang
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

3.  Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine.

Authors:  Gary Lu; Vinit Karur; Jon D Herrington; Mary G Walker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

4.  Levels of enzymes in leukaemic mice treated withAeromonas L-asparaginase.

Authors:  P J Benny; G Muraleedhara Kurup; K Sreejith
Journal:  Indian J Clin Biochem       Date:  1999-07

5.  Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase.

Authors:  P H Heidemann; P Stubbe; W Beck
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

6.  Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia.

Authors:  Y Hatta; J Takeuchi; T Ohshima; A Horikoshi; Y Iizuka; M Kawamura; M Kanemaru; T Horie
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

7.  A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Authors:  H B Muss; N Spell; D Scudiery; R L Capizzi; M R Cooper; J Cruz; D V Jackson; F Richards; C L Spurr; D R White
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.

Authors:  R L Lavine; I Brodsky; C D Garofano; L I Rose
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

9.  Parathyroid necrosis and hypocalcemic tetany induced in rabbits by L-asparaginase.

Authors:  F V Chisari; H D Hochstein; R L Kirschstein; E B Seligmann
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

Review 10.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.